Literature DB >> 10512639

Expression, purification, and characterization of Mycobacterium tuberculosis mycothione reductase.

M P Patel1, J S Blanchard.   

Abstract

Mycothione reductase from the human pathogen Mycobacterium tuberculosis has been cloned, expressed in Mycobacterium smegmatis, and purified 145-fold to homogeneity in 43% yield. Amino acid sequence alignment of mycothione reductase with the functionally homologous glutathione and trypanothione reductase indicates conservation of the catalytically important redox-active disulfide, histidine-glutamate ion pair, and regions involved in binding both the FAD cofactor and the substrate NADPH. The homogeneous 50 kDa subunit enzyme exists as a homodimer and is NADPH-dependent and highly specific for the structurally unique low-molecular mass disulfide, mycothione, exhibiting Michaelis constants of 8 and 73 microM for NADPH and mycothione, respectively. HPLC analysis indicated the presence of 1 mol of bound FAD per monomer as the cofactor exhibiting an absorption spectrum with a lambda(max) at 462 nm with an extinction coefficient of 11 300 M(-)(1) cm(-)(1). The reductive titration of the enzyme with NADH indicates the presence of a charge-transfer complex of one of the presumptive catalytic thiolates and FAD absorbing at ca. 530 nm. Reaction with serially truncated mycothione and other disulfides and pyridine nucleotide analogues indicates a strict minimal disulfide substrate requirement for the glucosamine moiety of mycothione. The enzyme exhibits bi-bi ping-pong kinetics with both disulfide and quinone substrates. Transhydrogenase activity is observed using NADH and thio-NADP(+), confirming the kinetic mechanism. We suggest mycothione reductase as the newest member of the class I flavoprotein disulfide reductase family of oxidoreductases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512639     DOI: 10.1021/bi991025h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  29 in total

1.  N-Acetyl-1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside deacetylase (MshB) is a key enzyme in mycothiol biosynthesis.

Authors:  G L Newton; Y Av-Gay; R C Fahey
Journal:  J Bacteriol       Date:  2000-12       Impact factor: 3.490

2.  Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis.

Authors:  Michael B Harbut; Catherine Vilchèze; Xiaozhou Luo; Mary E Hensler; Hui Guo; Baiyuan Yang; Arnab K Chatterjee; Victor Nizet; William R Jacobs; Peter G Schultz; Feng Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

Review 3.  Review of the chemistry and pharmacology of 7-Methyljugulone.

Authors:  Armelle T Mbaveng; Victor Kuete
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

4.  Identification of a TeO32- reductase/mycothione reductase from Rhodococcus erythropolis PR4.

Authors:  Zachary J Butz; Alexander Hendricks; Kanda Borgognoni; Christopher J Ackerson
Journal:  FEMS Microbiol Ecol       Date:  2020-12-29       Impact factor: 4.194

5.  Ellman's-reagent-mediated regeneration of trypanothione in situ: substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase.

Authors:  Chris J Hamilton; Ahilan Saravanamuthu; Ian M Eggleston; Alan H Fairlamb
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

Review 6.  New targets and inhibitors of mycobacterial sulfur metabolism.

Authors:  Hanumantharao Paritala; Kate S Carroll
Journal:  Infect Disord Drug Targets       Date:  2013-04

Review 7.  Bacillithiol: a key protective thiol in Staphylococcus aureus.

Authors:  Varahenage R Perera; Gerald L Newton; Kit Pogliano
Journal:  Expert Rev Anti Infect Ther       Date:  2015-07-16       Impact factor: 5.091

8.  Mycothiol is essential for growth of Mycobacterium tuberculosis Erdman.

Authors:  Dipti Sareen; Gerald L Newton; Robert C Fahey; Nancy A Buchmeier
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

Review 9.  Drug targets in mycobacterial sulfur metabolism.

Authors:  Devayani P Bhave; Wilson B Muse; Kate S Carroll
Journal:  Infect Disord Drug Targets       Date:  2007-06

10.  Ergothioneine Maintains Redox and Bioenergetic Homeostasis Essential for Drug Susceptibility and Virulence of Mycobacterium tuberculosis.

Authors:  Vikram Saini; Bridgette M Cumming; Loni Guidry; Dirk A Lamprecht; John H Adamson; Vineel P Reddy; Krishna C Chinta; James H Mazorodze; Joel N Glasgow; Melissa Richard-Greenblatt; Anaximandro Gomez-Velasco; Horacio Bach; Yossef Av-Gay; Hyungjin Eoh; Kyu Rhee; Adrie J C Steyn
Journal:  Cell Rep       Date:  2016-01-07       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.